LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

LENZ Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERLENZ
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / LENZ COVERAGE

What’s moving LENZ Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
Earnings preview: LENZ Therapeutics, Inc. (LENZ) Q2 earnings expected to decline

Earnings preview: LENZ Therapeutics, Inc. (LENZ) Q2 earnings expected to decline

Investors are testing whether LENZ Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
LENZ Therapeutics, Inc. (LENZ) Q1 2026 Earnings Call Transcript

LENZ Therapeutics, Inc. (LENZ) Q1 2026 Earnings Call Transcript

Investors are testing whether LENZ Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Citi's Biopharma Back To School Conference Transcript

LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Citi's Biopharma Back To School Conference Transcript

The story matters when it changes LENZ Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
LENZ Therapeutics, Inc. (LENZ) is a Great Momentum Stock: Should You Buy?

LENZ Therapeutics, Inc. (LENZ) is a Great Momentum Stock: Should You Buy?

Investors are testing whether LENZ Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
LENZ Therapeutics, Inc. (LENZ) Is Up 3.37% in One Week: What You Should Know

LENZ Therapeutics, Inc. (LENZ) Is Up 3.37% in One Week: What You Should Know

The story matters when it changes LENZ Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest LENZ filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-11 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-05 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-24 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-02 · Period 2026-06-30SEC ↗8-KMaterial company eventFiled 2026-06-12 · Period 2026-06-12SEC ↗8-KMaterial company eventFiled 2026-05-11 · Period 2026-05-11SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-28 · Period 2026-06-12SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-06-26SEC ↗
EARNINGS / QUARTERLY TRACKER

LENZ Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.